Summers Labs Blasts NAD “Secret Rules” After J&J Ointment Claim Clash
This article was originally published in The Rose Sheet
Executive Summary
Claims for Summers Labs’ Triple Paste diaper rash ointment spurred Desitin maker Johnson & Johnson to bring a challenge through the National Advertising Division. Summers disagreed with NAD’s conclusion on a physician survey it conducted and declined to discontinue a doctor-recommended claim.
You may also be interested in...
Maker Of Hair Removal Device Referred to FTC For Unresponsiveness
Canadian hair removal device marketer VISS Beauty is being referred to the Federal Trade Commission and FDA following its refusal to participate in the National Advertising Division review process.
Natural Organics ADHD Claims Prohibited Under FTC Complaint
Claims made by Natural Organics for its Pedi-Active A.D.D. dietary supplement improperly suggest the product treats attention deficit hyperactivity disorder and are "unfair or deceptive acts or practices," the Federal Trade Commission determines.
NaZura’s Lovidia Weight-Loss Supplement Strategy Focused On Brand Building
NaZura BioHealth, spun out from Elcelyx Therapeutics, will market its Lovidia weight-loss product in 2014 when it launches into the direct-response channel, before potential suitors get serious about acquiring the brand.